These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 23227838)

  • 21. MicroRNA epigenetic alterations: predicting biomarkers and therapeutic targets in human diseases.
    Wang Y; Liang Y; Lu Q
    Clin Genet; 2008 Oct; 74(4):307-15. PubMed ID: 18713257
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The complexities of microRNA regulation: mirandering around the rules.
    Breving K; Esquela-Kerscher A
    Int J Biochem Cell Biol; 2010 Aug; 42(8):1316-29. PubMed ID: 19800023
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential role of blood microRNAs as non-invasive biomarkers for early detection of asymptomatic coronary atherosclerosis in obese children with metabolic syndrome.
    Omran A; Elimam D; He F; Peng J; Yin F
    Med Hypotheses; 2012 Dec; 79(6):889-93. PubMed ID: 23062773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Approaches to the modulation of miRNA maturation.
    Tripp VT; McKenna JR; Young DD
    Methods Mol Biol; 2014; 1095():27-58. PubMed ID: 24166301
    [TBL] [Abstract][Full Text] [Related]  

  • 25. microRNAs as mediators of drug toxicity.
    Yokoi T; Nakajima M
    Annu Rev Pharmacol Toxicol; 2013; 53():377-400. PubMed ID: 23189953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miRNAs, polyphenols, and chronic disease.
    Bladé C; Baselga-Escudero L; Salvadó MJ; Arola-Arnal A
    Mol Nutr Food Res; 2013 Jan; 57(1):58-70. PubMed ID: 23165995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of microRNAs in cancer: diagnostic and prognostic biomarkers and targets of therapies.
    Corsini LR; Bronte G; Terrasi M; Amodeo V; Fanale D; Fiorentino E; Cicero G; Bazan V; Russo A
    Expert Opin Ther Targets; 2012 Apr; 16 Suppl 2():S103-9. PubMed ID: 22443195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma microRNAs serve as biomarkers of therapeutic efficacy and disease progression in hypertension-induced heart failure.
    Dickinson BA; Semus HM; Montgomery RL; Stack C; Latimer PA; Lewton SM; Lynch JM; Hullinger TG; Seto AG; van Rooij E
    Eur J Heart Fail; 2013 Jun; 15(6):650-9. PubMed ID: 23388090
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Advances of utilizing microRNAs as biomarkers].
    Qiao J; Jin R
    Zhongguo Zhong Yao Za Zhi; 2012 Aug; 37(15):2202-5. PubMed ID: 23189718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating MicroRNAs as potential biomarkers for alcoholic steatohepatitis.
    Chen YP; Jin X; Xiang Z; Chen SH; Li YM
    Liver Int; 2013 Sep; 33(8):1257-65. PubMed ID: 23682678
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating microRNAs as novel minimally invasive biomarkers for breast cancer.
    Heneghan HM; Miller N; Lowery AJ; Sweeney KJ; Newell J; Kerin MJ
    Ann Surg; 2010 Mar; 251(3):499-505. PubMed ID: 20134314
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of circulating microRNA by microarray in liver disease.
    Murakami Y; Tanahashi T
    Methods Mol Biol; 2013; 1024():173-82. PubMed ID: 23719950
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of microRNAs in human diseases.
    Tüfekci KU; Oner MG; Meuwissen RL; Genç S
    Methods Mol Biol; 2014; 1107():33-50. PubMed ID: 24272430
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tissular and soluble miRNAs for diagnostic and therapy improvement in digestive tract cancers.
    Albulescu R; Neagu M; Albulescu L; Tanase C
    Expert Rev Mol Diagn; 2011 Jan; 11(1):101-20. PubMed ID: 21171925
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genome-wide microRNA expression profiling in idiopathic non-obstructive azoospermia: significant up-regulation of miR-141, miR-429 and miR-7-1-3p.
    Wu W; Qin Y; Li Z; Dong J; Dai J; Lu C; Guo X; Zhao Y; Zhu Y; Zhang W; Hang B; Sha J; Shen H; Xia Y; Hu Z; Wang X
    Hum Reprod; 2013 Jul; 28(7):1827-36. PubMed ID: 23559187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating miRNAs as sensitive and specific biomarkers for the diagnosis and monitoring of human diseases: promises and challenges.
    De Guire V; Robitaille R; Tétreault N; Guérin R; Ménard C; Bambace N; Sapieha P
    Clin Biochem; 2013 Jul; 46(10-11):846-60. PubMed ID: 23562576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Utility of circulating microRNAs as clinical biomarkers for cardiovascular diseases.
    Kondkar AA; Abu-Amero KK
    Biomed Res Int; 2015; 2015():821823. PubMed ID: 25710029
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNAs as paracrine signaling mediators in cancers and metabolic diseases.
    Matsuda A; Yan IK; Foye C; Parasramka M; Patel T
    Best Pract Res Clin Endocrinol Metab; 2016 Oct; 30(5):577-590. PubMed ID: 27923452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNAs in metabolic disease.
    Fernández-Hernando C; Ramírez CM; Goedeke L; Suárez Y
    Arterioscler Thromb Vasc Biol; 2013 Feb; 33(2):178-85. PubMed ID: 23325474
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA Regulators of Anxiety and Metabolic Disorders.
    Meydan C; Shenhar-Tsarfaty S; Soreq H
    Trends Mol Med; 2016 Sep; 22(9):798-812. PubMed ID: 27496210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.